Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Overview of preclinical and clinical evaluation of Russian nitrosourea

March 9, 1998

S-1 demonstrates excellent antitumor activity in phase II

March 9, 1998

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

March 6, 1998

Antitumor agents isolated from fungal strains by Roche

March 6, 1998

PKC antisense oligonucleotide shows promise in cancer therapy

March 6, 1998

Purdue discloses antitumor selenophene compounds

March 5, 1998

Colchicine analogues from Indena show potential for resistant tumors

March 5, 1998

Chemopotentiating agents in R&D at Nippon Flour Milling

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...